Is Roivant Sciences Ltd (ROIV) a good stock to buy now?

Roivant Sciences Ltd (NASDAQ: ROIV) is -4.95% lower on its value in year-to-date trading and has touched a low of $8.73 and a high of $13.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ROIV stock was last observed hovering at around $11.17 in the last trading session, with the day’s gains setting it 0.07%.

Currently trading at $11.24, the stock is 2.90% and 5.90% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.1 million and changing 0.67% at the moment leaves the stock -0.19% off its SMA200. ROIV registered 8.23% gain for a year compared to 6-month loss of -11.39%. The firm has a 50-day simple moving average (SMA 50) of $10.6098 and a 200-day simple moving average (SMA200) of $11.26755.

The stock witnessed a -2.05% gain in the last 1 month and extending the period to 3 months gives it a 8.96%, and is 4.51% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.70% over the week and 2.40% over the month.

Roivant Sciences Ltd (ROIV) has around 750 employees, a market worth around $7.64B and $76.19M in sales. Profit margin for the company is -225.71%. Distance from 52-week low is 28.81% and -13.86% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.60%).

with sales reaching $7.16M over the same period.The EPS is expected to shrink by -386.31% this year, but quarterly earnings will post 0.63% year-over-year. Quarterly sales are estimated to shrink -87.02% in year-over-year returns.

Roivant Sciences Ltd (ROIV) Top Institutional Holders

410.0 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 120.80% of the company’s shares. The shares outstanding are 695.94M, and float is at 417.69M with Short Float at 11.79%. Institutions hold 83.47% of the Float.

The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 71.36 million shares valued at $754.29 million. The investor’s holdings represent 9.6983% of the ROIV Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.16 million shares valued at $$730.98 million to account for 9.3985 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 9.0674% and valued at over $705.23 million, while FMR LLC holds 6.3265 of the shares totaling 46.55 million with a market value of $492.05 million.

Roivant Sciences Ltd (ROIV) Insider Activity

#####

Still, SEC filings show that on May 20 ’25, Venker Eric (President & COO) disposed off 100,000 shares at an average price of $10.95 for $1.09 million. The insider now directly holds 1,077,197 shares of Roivant Sciences Ltd (ROIV).

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.